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In advanced atherosclerosis, macrophage apoptosis
coupled with defective phagocytic clearance of the
apoptotic cells (efferocytosis) promotes plaque
necrosis, which precipitates acute atherothrombotic
cardiovascular events. Oxidative and endoplasmic
reticulum (ER) stress in macrophages are important
causes of advanced lesional macrophage apoptosis.
We now show that proapoptotic oxidative/ER stress
inducers trigger another stress reaction in macro-
phages, autophagy. Inhibition of autophagy by
silencing ATG5 or other autophagy mediators
enhances apoptosis and NADPH oxidase-mediated
oxidative stress while at the same time rendering
the apoptotic cells less well recognized by effero-
cytes. Most importantly, macrophage ATG5 defi-
ciency in fat-fed Ldlr/ mice increases apoptosis
and oxidative stress in advanced lesional macro-
phages, promotes plaque necrosis, and worsens
lesional efferocytosis. These findings reveal a pro-
tective process in oxidatively stressed macro-
phages relevant to plaque necrosis, suggesting a
mechanism-based strategy to therapeutically sup-
press atherosclerosis progression and its clinical
sequelae.
INTRODUCTION
In advanced atherosclerosis, death of lesional macrophages,
coupled with defective phagocytic clearance of the dead cells
(‘‘efferocytosis’’), promotes the formation of plaque necrosis (Ta-
bas, 2010). Plaque necrosis is a key distinguishing feature of and
likely causative process in the small percentage of atheroscle-
rotic lesions that cause acute atherothrombotic vascular
disease, such as myocardial infarction, sudden cardiac death,
and stroke (Virmani et al., 2002). In vivo data suggest that endo-
plasmic reticulum (ER) and oxidative stress play important rolesCin advanced lesional macrophage death (Lusis, 2000; Moore and
Tabas, 2011). When macrophages are exposed to atheroscle-
rosis-relevant factors that trigger these stress reactions, such
as oxysterols, oxidized phospholipids (oxPLs), or unesterified
‘‘free’’ cholesterol (FC), ER stress-induced apoptotic pathways
are activated (Lusis, 2000; Moore and Tabas, 2011). Moreover,
the NOX2 subunit of NADPH oxidase is induced, leading to
assembly of active NADPH oxidase complex on lysosomes
and proapoptotic oxidative stress (Li et al., 2010; Seimon et al.,
2010). In response to cell death, efferocytosis is normally rapid
and efficient and thereby prevents postapoptotic necrosis and
inflammation (Henson et al., 2001), but for reasons that are not
yet known, efferocytosis is defective in advanced atheroscle-
rosis (Schrijvers et al., 2005; Tabas, 2010).
In an attempt to increase our understanding in these areas, we
decided to explore the process of autophagy, which can affect
both apoptosis and efferocytosis in other settings (Eisenberg-
Lerner et al., 2009; Qu et al., 2007). In this regard, we set out
to explore how autophagy may affect these processes in
advanced atherosclerosis by genetically preventing the auto-
phagic response in macrophages exposed to oxidative/ER
stressors in vitro and in advanced atherosclerotic lesions in vivo.
We show that blocking autophagy renders macrophages more
susceptible to cell death, worsens the recognition and clearance
of the dead cells by efferocytes, and promotes plaque necrosis
in a mouse model of advanced atherosclerosis.RESULTS
Autophagy Is Induced in Macrophages Exposed to
Atherosclerosis-Related Stimulators of Apoptosis
Primary macrophages from mice transgenic for a GFP-tagged
version of the autophagy effector LC3-II were treated for 6 hr
with 7-ketocholesterol (7KC), an atherosclerotic lesional oxy-
sterol that promotes oxidative stress, ER stress, and apoptosis
in macrophages (Lizard et al., 1998; Myoishi et al., 2007; Li
et al., 2010). The 7KC-treated macrophages showed a punctate
pattern of fluroscence that is indicative of autophagy induction
(Mizushima et al., 2010) (Figure 1A). At the ultrastructural
level (Figure 1B), 7KC-treated macrophages had numerous
double-membrane structures that were characteristic ofell Metabolism 15, 545–553, April 4, 2012 ª2012 Elsevier Inc. 545
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Figure 1. Autophagy Is Induced in Macrophages
Exposed to Atherosclerosis-Related Stimulators
of Apoptosis
(A) Confocal fluorescence microscopy of macrophages
from GFP-LC3 transgenic mice that were left untreated
or treated for 8 hr with 35 mM7-ketocholesterol (7KC). Bar,
10 mm.
(B) Electron microscopy of macrophages from WT or
Atg5fl/flLysmCre+/mice that were left untreated or treated
for 6 hr with 7KC or 50 mg/ml of KOdiA-PC plus 0.5 mM
thapsigargin (KOdiA-PC + Tg). Double membranes are
depicted by arrows. Bar, 100 nm for left and middle row
of images and 500 nm for right row of images. Quantifi-
cation of the average number of autophagosomes per
cell section in untreated and 7KC-treated WT and
Atg5fl/flLysmCre+/ macrophages is shown (mean ± SEM;
*p < 0.01 versus other groups; n = 10 cell sections/group).
(C) Macrophages from WT or Atg5fl/flLysmCre+/ mice
were left untreated or incubated for 4 hr with 7KC. In some
groups, 10 mM bafilomycin A1 (Baf) was added during the
last 2 hr. Cell extracts were probed for LC3-I, LC3-II, Atg5,
CHOP, and b-actin by immunoblot. Densitometric quan-
tification of the WT immunoblot data is shown in the graph
(mean ± SEM; *,**p < 0.05 versus the other groups and
each other).
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Macrophage Autophagy in Advanced Atherosclerosisautophagosomes. We also explored macrophages incubated
with KOdiA-PC, an oxPL typical of those in oxidized LDL, in
combination with low-dose thapsigargin, which induces ER
stress by inhibiting calcium reentry into the ER (Seimon
et al., 2010). These macrophages also showed the presence of
double membrane structures. In contrast, there were very few
double membranes in untreated macrophages or in 7KC-treated
macrophages from Atg5fl/flLysmcre+/ mice, which lack the
key autophagy protein ATG5 (Hara et al., 2006). To further
document autophagy, we assayed the expression of LC3-II,
which is converted from LC3-I during the early stages of autoph-
agy (Mizushima et al., 2010) (Figure 1C, lanes 1–3 and 7–9).
When macrophages were incubated with 7KC for 4 hr, the
expression level of LC3-II was higher than baseline, whereas
only the precursor LC3-I was detectable in ATG5-deficient
macrophages.
The final stage of autophagy, autophagosome-lysosome
fusion, leads to lysosomal degradation of autophagosomal con-
tent and proteins, including LC3-II itself. This process of ‘‘flux’’546 Cell Metabolism 15, 545–553, April 4, 2012 ª2012 Elsevier Inc.through lysosomes can be documented by
showing a higher level of LC3-II in the presence
versus the absence of the lysosomal inhibitor
bafilomycin A1 (Mizushima et al., 2010). We
found that 7KC treatment of WT macrophages,
but not ATG5-deficient macrophages, in-
creased the difference between the minus-
and plus-bafilomycin LC3-II signal, indicative
of autophagic flux through lysosomes (Fig-
ure 1C, lanes 4–6 and 10–12). Similar data
were obtained in macrophages incubated with
KOdiA-PC/thapsigargin and in macrophages
loaded with FC (data not shown). These
combined data provide strong evidence that
7KC and other inducers of macrophageapoptosis relevant to atherosclerosis induce autophagy and
promote autophagic flux through lysosomes.
Inhibition of Autophagy Increases Apoptosis
in Macrophages
To test the role of autophagy in apoptosis, we treated wild-type
(WT) and Atg5fl/flLysmcre+/ mice with a number of different
inducers and found markedly higher cell death in the autoph-
agy-defective macrophages (Figures 2A and 2B and see
Figure S1A online). Note that Figure 2A includes macrophages
treated with thapsigargin plus apolipoprotein(a), an atherogenic
protein in humans that induces apoptosis in ER-stressedmacro-
phages through its bound oxPLs (Clarke et al., 2009; Seimon
et al., 2010). Apoptosis was also enhanced in a more acute
model of autophagy inhibition in which ATG5 or the autophagy
effector Beclin1 was silenced using siRNA (Figure 2C).
As shown in Figure 2B, thapsigargin alone at the dose and time
used here showed only a very slight, nonsignificant trend toward
increased apoptosis over baseline, and apoptosis was not
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Figure 2. Inhibition of Autophagy Increases Apoptosis and NADPH Oxidase-Mediated Oxidative Stress
For (A)–(D), macrophages from WT or Atg5fl/flLysmCre+/ mice were left untreated (Un) or incubated as below and then assayed for apoptosis by annexin V
staining (mean ± SEM; *p < 0.05, **p < 0.01 versus the other groups).
(A) Incubation times were 20 hr for 7KC, 18 hr for free cholesterol (FC)-loading, and 20 hr for 50 mg/ml apolipoprotein(a) (Apo[a]) plus 0.5 mM thapsigargin (Tg).
(B) Incubation time was 24 hr for 50 mg/ml of KOdiA-PC alone, 0.5 mM thapsigargin (Tg) alone, or both reagents together.
(C) As in (B), but the cells were pretreated for 90 hr with either scrambled RNA (Scr) or siRNA targeting Atg5 or Becn1.
(D) Incubation times were 24 hr for 2.5 or 5.0 mg/ml tunicamycin (Tun).
(E) Lysmcre+/ (control) and Atg5fl/flLysmcre+/ mice were injected i.v. with 0.02 mg/kg tunicamycin, and 16 hr later freshly harvested peritoneal macrophages
were assayed for apoptosis using annexin V (mean ± SEM; *p < 0.05).
(F) Incubation time was 20 hr for 7KC in the absence or presence of either 20 nM bafilomycin A1 or 10 mg/ml of pepstatin plus 10 mg/ml of E64D.
(G) Macrophages from WT or Atg5fl/flLysmcre+/ mice were left untreated or incubated with the indicated reagents as above. The cells were then stained with
DCFDA, viewed by fluorescence microscopy, and quantified for the percent of DCF-positive cells (mean ± SEM; *p < 0.05, **p < 0.01 versus the other groups).
(H) Macrophages from Nox2+/+ or Nox2/mice were left untreated or incubated with KOdiA-PC plus thapsigargin and then assayed for apoptosis, except some
of the cells were pretreated for 90 hr with scrambled RNA or Atg5 siRNA. The inset shows the immunoblot of ATG5 and b-actin in macrophages treated with
scrambled RNA or Atg5 siRNA (mean ± SEM; *p < 0.05, **p < 0.01 versus the other groups; n.s., not significant).
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Macrophage Autophagy in Advanced Atherosclerosissignificantly increased in ATG5-deficient macrophages.
However, tunicamycin, which induces ER stress by inhibiting
protein glycosylation, did induce apoptosis, and this was further
enhanced by ATG5 deficiency (Figure 2D). In this context, we
explored a mouse model in which i.v. tunicamycin induces apo-
ptosis of peritoneal macrophages in vivo (Li et al., 2009) and
found that apoptosis was 2-fold higher in Atg5fl/flLysmcre+/
versus control Lysmcre+/ mice (Figure 2E).
To test the importance of autophagic flux through lysosomes
in the antiapoptotic effect of autophagy, WT macrophages
were treated with 7KC either in the absence or the presence of
bafilomycin A1 or the combination of pepstatin and E64D, which
is another means to inhibit proteolysis in autophagosomes.
Apoptosis was substantially increased in the presence of the
lysosomal inhibitors (Figure 2F), suggesting that the protective
effect of autophagy requires the full process of autophagic flux
through lysosomes.
Manymacrophages in atherosclerotic lesions are ‘‘foam cells’’
filled with cholesteryl ester (CE). Although CE loading per se
does not cause apoptosis (Feng et al., 2003a), we askedwhether
it would affect the increase in KOdiA-PC/thapsigargin-induced
apoptosis caused by autophagy inhibition (Figure S1B). The
data show that in foam cells, as in nonfoam cells, ATG5 defi-
ciency enhanced KOdiA-PC/thapsigargin-induced apoptosis.
Interestingly, ATG5 deficiency also significantly increased
apoptosis in nontreated foam cells, suggesting that CE loading,
while not inducing apoptosis by itself, renders the cells more
sensitive to the proapoptotic effect of autophagy inhibition.
The fact that macrophages exposed to the proapoptotic
inducers used here eventually die suggests that either the
prolonged effect of proapoptotic processes overwhelms the
protective effect of autophagy or that death occurs because
the autophagic response eventually decreases. Indeed, we
found that LC3-II flux through lysosomes was lower in macro-
phages exposed to 7C for 16–18 hr versus 6 hr (Figure S1C),
and this was not associated with a general defect in lysosomal
function (Figure S1D). However, when the late decrease in
flux was prevented by treatment with rapamycin at the 12 hr
time point or by adenoviral-mediated transduction with ATG7
(Pattison et al., 2011) (Figure S1E), 7KC-induced apoptosis
was not decreased (Figure S1F). These data suggest that the
late decrease in autophagolysosomal flux is an effect rather
than a trigger of apoptosis and that the protective effect of au-
tophagy is eventually overwhelmed by ongoing proapoptotic
processes.
Autophagy Inhibition Increases NADPH
Oxidase-Mediated Oxidative Stress
NADPH oxidase-mediated oxidative stress is a major mecha-
nism of apoptosis in macrophages exposed to the inducers
used in this study (Li et al., 2010; Seimon et al., 2010). To eval-
uate its role in autophagy-inhibited macrophages, we first
compared WT and ATG5-deficient macrophages for DCF stain-
ing, which fluoresceces in the presence of peroxide in a manner
parallel to NADPH oxidase activation in ER-stressed macro-
phages (Li et al., 2010). In all models tested, the percentage of
DCF-positive cells was substantially higher in the autophagy-
defective group (Figure 2G). Similar data were obtained using
a FACS assay for cells stained with CellRox, which is nonfluores-548 Cell Metabolism 15, 545–553, April 4, 2012 ª2012 Elsevier Inc.cent in the reduced state but exhibits excitation/emission max-
ima at 640/665 nm upon oxidation (Figure S2A).
We next used a genetic approach to test the role of NADPH
oxidase in theenhancementof apoptosisbyautophagy inhibition.
The experiment is based on the idea that there are two ‘‘compo-
nents’’ of apoptosis in autophagy-inhibited macrophages: the
‘‘basal’’ level that occurs in autophagy-competent cells, which
is suppressed by NOX2 deficiency (Li et al., 2010), and the
additional increment above this level that occurs in autophagy-
inhibitedcells. If this incremental component is alsoNOX2depen-
dent, NOX2 deficiency should not only decrease the high level of
apoptosis seen in autophagy-inhibited cells to a very low level,
but it should also eliminate the difference in apoptosis between
autophagy-competent and autophagy-inhibited cells. We there-
fore compared KOdiA-PC/thapsigargin-induced apoptosis in
Nox2+/+ versus Nox2/ macrophages treated with scrRNA or
Atg5 siRNA to inhibit autophagy (Figure 2H). The data show that
NOX2 deficiency markedly inhibited apoptosis in ATG5-silenced
macrophages, and the low level of residual apoptosis was similar
to that in autophagy-competent (scrRNA)Nox2/macrophages.
Similar results were obtained using 7KC as the apoptosis inducer
(data not shown). In theory, NOX2 deficiency could protect
macrophages by increasing autophagy, but this was not the
case (Figure S2B). These data are consistent with the hypothesis
that autophagy inhibition enhances apoptosis, at least in part, by
enhancing NADPH oxidase-induced oxidative stress.
To further explore this hypothesis, we considered two recent
findings. First, NADPH oxidase-induced oxidative stress and
apoptosis in macrophages are associated with the assembly of
NADPH oxidase complex on lysosomes (Seimon et al., 2010).
Second, autophagy in macrophages can participate in the clear-
ance of phagocytosed bacteria in NADPH oxidase-containing
phagolysosomes (Huang et al., 2009), and so NADPH oxidase
complex itself may be disrupted in the process as part of
a homeostatic mechanism to protect the cells against excessive
oxidative stress. If so, NADPH oxidase-activated macrophages,
such as those occurring in the models explored here, would
depend on autophagy to limit the oxidative damage. To test
this idea, we used the fluorescence microscopy assay estab-
lished in the aforementioned study to quantify the association
of the NADPH oxidase subunit p47phox with lysosomes (Seimon
et al., 2010), with the prediction that autophagy inhibition would
disallow the disruption of NADPH oxidase complex and thus
increase p47phox-lysosome association. Consistent with our
previous data (Seimon et al., 2010), incubation of WT macro-
phages with KOdiA-PC/thapsigargin, but not either factor alone,
increased p47phox-lysosome association (Figure S2C, black
bars). As predicted by the hypothesis, p47phox association was
increased by 55% in ATG5-deficient macrophages (Fig-
ure S2C, gray bars), which was not simply due to an increase
in Nox2 induction (Figure S2D). Importantly, inhibition of auto-
phagolysosomal flux with bafilomycin in WT macrophages was
able to mimic the effect of ATG5 deficiency, and p47phox-lyso-
some association was not further increased in this setting by
ATG5 deficiency. Similar results were obtained with 7KC (data
not shown). In summary, the combined data in this section
and in previous studies (Li et al., 2010; Seimon et al., 2010;
Huang et al., 2009) support the idea that increased apoptosis
in autophagy-inhibited cells involves increased NADPH
Cell Metabolism
Macrophage Autophagy in Advanced Atherosclerosisoxidase-induced oxidative stress, possibly through a process
that increases lysosome-associated p47phox.
Defective Macrophage Autophagy Promotes Plaque
Necrosis, Macrophage Apoptosis, and Oxidative Stress
in Advanced Atherosclerosis
In preparation for the atherosclerosis project using
Atg5fl/flLysmcre+/-Ldlr/ mice, we first showed that the aortic
root lesions of western diet (WD)-fed GFP-LC3-Ldlr/ mice
contain cells in macrophage-rich regions that express ATG5
and have macrophages that display a punctate pattern of
GFP-LC3 fluorescence typical of autophagy (Figure 3A). We
then looked for another autophagy protein, p62/SQSTM1, which
is known to accumulate when autophagy flux through lysosomes
is defective, i.e., through decreased p62 lysosomal degradation
(Bjorkoy et al., 2009) (Figure 3B). p62 immunofluorescence was
present in 10%–15% of intimal cells in macrophage-rich areas
of lesions of 8 week WD-fed Ldlr/ mice, and this value
increased as lesions progressed in 12 week and 16 week WD-
fed mice. Interestingly, p62 staining was observed in a few of
the acellular necrotic areas in 16 week lesions, which likely
reflects the residual debris frommacrophages that had accumu-
lated p62 before they died (Ball et al., 1995; Feng et al., 2003b).
Note that the mRNA for Sqstm1 did not increase between 8 and
16 weeks of WD, indicating that the increase in p62 was not due
to transcriptional induction (Figure 3B, right graph). These data
further substantiate the presence of autophagy in atherosclerotic
lesions and are consistent with the concept that autophagic flux
through lysosomes decreases as plaques progress.
To test the functional role of macrophage autophagy in ad-
vanced atherosclerosis, we studied 12 week and 16 week WD-
fed Lysmcre+/Ldlr/ (control) and Atg5fl/flLysmcre+/Ldlr/
mice.Despitenodifference inbodyweight,plasma lipidsand lipo-
proteins, andplasma insulin between the twogroups ofmice (Fig-
uresS3A andS3B), lesion andnecrotic area in the aortic rootwere
higher in Atg5fl/flLysmcre+/-Ldlr/ versus control mice at both
time points (Figures 3C and 3D and Figure S3C). The increase in
lesion size appeared to be due to the increase in necrotic areas,
because the numbers of lesional macrophages and smooth
muscle cells were not increased in the experimental cohort
(data not shown). This finding is consistent with the mechanistic
hypothesis described herein as opposed to an alternative possi-
bility in which a different process, such as macrophage influx or
SMC proliferation, might be increased by autophagy inhibition.
Consistent with the mechanistic data in Figure 2 and Figure 3,
quantitative analysis revealed that macrophage-rich regions of
the Atg5fl/flLysmcre+/Ldlr/ plaques had more cells positive
for TUNEL, activated caspase-3, DHE, and p47 than similar
regions in control Lysmcre+/Ldlr/ plaques (Figures 4A and
4B and Figures S4A and S4B). The increase in apoptosis in the
experimental groupwas not associatedwith an increase in lesion
Chop expression (Figure S4C), which is consistent with the
macrophage data in Figure 1C.
Defective Autophagy in Apoptotic Macrophages
Decreases Their Phagocytic Clearance In Vitro and in
Atherosclerosis
The increase in plaque necrosis in the ATG5-deficient mice
raised the possibility that the macrophages in these mice hadCa defect in efferocytosis (Henson et al., 2001; Tabas, 2010).
We therefore conducted an in situ efferocytosis assay, which
quantifies the ratio of TUNEL-labeled apoptotic cells in lesions
that are associated with F4/80-labeled macrophages versus
unassociated with macrophages (‘‘free’’) (Thorp et al., 2008).
The data show a marked decrease in the associated:free ratio
in the lesions of themutant mice, indicative of defective efferocy-
tosis (Figure 4C). To examine this point in a more controlled in vi-
tro setting, we first compared the ability of ATF5-deficient versus
control macrophages to engulf apoptotic cells and found equal
competency (data not shown). We therefore tested whether
apoptotic cells that die with defective autophagy are poorly en-
gulfed by efferocytes. To this end, WT or ATG5-deficient macro-
phages, or WT macrophages treated with bafilomycin A1, were
rendered apoptotic by incubation with 7KC and then labeled
with Alexa 595 annexin V (red). Equal numbers of labeled
apoptotic cells were added to Calcein-AM (green)-labeled WT
macrophages as a source of efferocytes. The data show that
there was less efferocytosis of apoptotic cells that were either
ATG5 deficient or had inhibited autophagolysosomal flux (bafilo-
mycin) (Figure 4D). The defect appeared to be in apoptotic cell-
efferocyte binding, because the inhibitory effect of apoptotic cell
ATG5 deficiency on efferocytosis was recapitulated in a 4C
binding assay (Figure 4E). We also found that when the late
decrease in autophagic flux in WT cells undergoing apoptosis
was bolstered by rapamycin or adeno-Atg7 (see Figure S1C),
their efferocytosis was increased (Figure S4D). Thus, autophagic
flux through lysosomes in macrophages undergoing apoptosis
enhances their recognition by phagocytes, and this process
can be enhanced further by bolstering autophagy.
DISCUSSION
The data in this study focus on functional relationships between
autophagy and two critical cell biological processes in athero-
sclerotic plaque necrosis, Mf apoptosis and defective efferocy-
tosis. We found that when autophagy was inhibited in vitro and
in vivo, apoptosis was increased and recognition of the autoph-
agy-inhibited dead cells by efferocytic phagocytes was
decreased. We infer from these data that autophagy can induce
two independent protective actions, which in normal physiology
may function to delay cell death in case repair is possible but also
ensure that the cells are efficiently cleared by neighboring
phagocytes if repair is not possible.
The findings herein raise a number of interesting mechanistic
questions for future study. First, the type of autophagy that is
involved in protection from apoptosis and oxidative stress and
in mediating efficient efferocytosis needs to be defined. The
finding of double membranes in our cell culture model indicates
that autophagy is occurring, but it is theoretically possible that an
additional single-membrane process involving LC3-II, ATG5,
and Beclin1, such as LC3-associated phagocytosis (LAP)
(Martinez et al., 2011; Florey et al., 2011), is also operational.
Moreover, whether the effects on apoptosis, oxidative stress,
and efferocytosis involve classic macroautophagy or, for
example, chaperone-mediated autophagy or mitophagy
remains to be established. While our data implicate the role
of NADPH oxidase, they do not rule out other sources of oxida-
tive stress, such as mitochondria, which could be affected byell Metabolism 15, 545–553, April 4, 2012 ª2012 Elsevier Inc. 549
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Figure 3. Defective Macrophage Autophagy Promotes Plaque Necrosis in Advanced Atherosclerotic Lesions of Western Diet-Fed Ldlr–/–
Mice
(A) Female GFP-LC3-Ldlr/ mice were fed the WD for 12 weeks. Cross-sections of an aortic root lesion were immunostained with anti-ATG5 or control IgG
(top images; bar, 20 mm) or with anti-F4/80 antibody and viewed by confocal fluorescence microscopy (bottom image; red, F4/80; green, GFP-LC3; bar, 10 mm).
(B) Female Lysmcre+/Ldlr/ (control) and Atg5fl/flLysmcre+/Ldlr/ mice were fed the WD for 8, 12, or 16 weeks (n = 5 per group). Lesions were then
immunostained for p62/SQSTM1 and DAPI (nuclei), and lesional Sqstm1 mRNA was assayed by LCM-RT-qPCR (mean ± SEM; *p = 0.02 versus 8 week value;
n.s., not significant). Representative images for the p62 immunostaining data are shown for the 8 and 16 week lesions, along with a nonimmune control image for
a 16 week lesion. Bar, 20 mm. In these images, the intima, which is composedmostly of macrophages, is outlined by the solid white lines, and areas of the 8 week
intima that have cells negative for p62 are outlined by the dotted yellow line.
(C and D) Aortic root sections of female Lysmcre+/Ldlr/ (control) and Atg5fl/flLysmcre+/Ldlr/mice fed theWD for 12 or 16 weeks were stained with H&E and
then quantified for lesion and necrotic area. Representative images are shown for the 12week groups. N, necrotic area; bar, 20 mm (mean ± SEM; *p < 0.05; N con/
experimental = 15/15 for the 12 week cohort and 17/15 for the 16 week cohort).
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Figure 4. Defective Macrophage Autophagy Promotes Apoptosis, Oxidative Stress, and Defective Efferocytosis
(A and B) Sections from the 12 week cohort in Figure 3 were stained for TUNEL, activated caspase-3, or DHE and then counterstained with DAPI (nuclei) and
quantified (mean ± SEM; *p < 0.05; n = 15 con/15 experimental). Bar, 20 mm.
(C) The lesions were stained for TUNEL and for F4/80 (macrophages), and the ratio of TUNEL-positive cells that were F4/80 associated or not (‘‘free’’) was
quantified (mean ± SEM; *p < 0.05; n = 15 con/15 experimental).
(D) Macrophages fromWT or Atg5fl/flLysmCre+/mice were rendered apoptotic using 7KC; one set of WT cells was also treated with bafilomycin A1 (Baf). These
cells were then added to WT macrophages, and efferocytosis was assayed and expressed as the percent of WT macrophages with ingested apoptotic cells
(mean ± SEM; *p < 0.01).
(E) The experiment labeled ‘‘37C’’ was similar to the first and second experimental groups in (D). The experiment labeled ‘‘4C’’ assayed the binding of WT and
Atg5fl/flLysmCre+/ apoptotic macrophages to WT macrophages (mean ± SEM; *p < 0.01).
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factors studied here, and those that actually function in athero-
sclerotic lesions, induce autophagy is not known. While ER
stress has been reported to induce autophagy (Kroemer et al.,
2010), we found that silencing key molecules in the IRE1 and
PERK branches of the UPR did not block autophagy initiation
or flux through lysosomes (data not shown). Third, the mecha-
nism involved in defective efferocytosis of autophagy-inhibited
apoptotic macrophages requires further study. The data here
indicate that autophagosomal flux through lysosomes in cells
undergoing apoptosis somehow increases their recognition byCphagocytes, perhaps by increasing the expression of a cell-
surface recognition molecule. However, we found no evidence
of a defect in PS externalization or presentation of three other
efferocytosis ligands, calreticulin, ERp57, and pentraxin 3, in au-
tophagy-inhibited macrophages (data not shown).
Future studies will likely reveal additional roles of autophagy in
atherosclerosis that are cell type and lesion stage specific. For
example, previous work has shown that intimal smooth muscle
cells can acquire morphological features suggestive of autoph-
agy (De Meyer and Martinet, 2009), although the functional
significance of this finding is unknown. Links between autophagyell Metabolism 15, 545–553, April 4, 2012 ª2012 Elsevier Inc. 551
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Macrophage Autophagy in Advanced Atherosclerosisand inflammation have been implicated in other disease models
(Levine et al., 2011), which could be important in atherosclerosis
if such processes occurred in lesional cells. A recent study re-
vealed that autophagy can play a role in the hydrolysis of stored
CE droplets in macrophages, thus facilitating cholesterol efflux
(Ouimet et al., 2011), but the relevance of this finding to athero-
sclerosis remains to be determined. Knowledge gained from au-
tophagy studies in atherosclerosis may be useful for devising
mechanism-based therapeutic strategies. Although increasing
autophagy above the induced level with rapamycin or ATG7
transduction did not protect macrophage in vitro, autophagy
appears to be defective in advanced atherosclerosis, and so
restoring autophagy to the normally induced level may be
protective. Moreover, boosting autophagy did improve efferocy-
tosis in vitro, which may translate into a beneficial effect in
advanced atherosclerosis (Tabas, 2010). Such strategies would
be unique, because autophagy may be the macrophage’s
natural way to combat two complementary processes in plaque
necrosis, macrophage apoptosis and defective efferocytosis.
EXPERIMENTAL PROCEDURES
Animals and Diets
C57BL/6J, Ldlr /, Nox2 /, and ob/ob mice were purchases from Jackson
Laboratory (Bar Harbor, Maine). The GFP-LC3 transgenic and Atg5fl/fl mice
(Mizushima and Kuma, 2008; Hara et al., 2006) were created by Dr. Noboru
Mizushima, TokyoMedical and Dental University, and sent to us from the labo-
ratory of Dr. Beth Levine (UT Southwestern). The Lysmcre+/ mice (Clausen
et al., 1999) were from Dr. Irmgard Fo¨ster (Technical University of Munich).
The Ldlr/, Atg5fl/fl, and Lysmcremice were bred with each other to generate
the mice used for this study. For the atherosclerosis study, 8-week-old female
mice were placed on a western-type diet (TD88137; Harlan Teklad) for the indi-
cated number of weeks. All mouse protocols were approved by the Columbia
University Institutional Animal Care and Use Committee.
Apoptosis Assays
Apoptosis was assayed in cultured macrophages by staining with Alexa
488-conjugated annexin V or using the TUNEL (TdT-mediated dUTP nick-
end labeling) protocol, as described previously (Seimon et al., 2010). Apoptotic
cells in atherosclerotic lesions were labeled by TUNEL using the in situ cell
death detection kit TMR-red (Roche Diagnostics) according to the manufac-
turer’s protocol. Only TUNEL-positive cells that colocalized with DAPI-stained
nuclei were counted as being positive. Lesional apoptosis was also assayed
by immunofluorescence using anti-activated caspase-3 primary antibody.
TUNEL, annexin V, and activated caspase-3 staining were viewed using an
Olympus IX-70 inverted fluorescent microscope. Representative fields (four
to six fields containing 2000 cells) were photographed using an Olympus
DP71CCDcamera. The annexin V-positive cells were counted and the number
expressed as a percent of the total number of cells in at least four separate
fields from duplicate wells. For TUNEL analysis of lesions, DAPI and TUNEL
images were merged using Photoshop analysis software (Adobe Systems).
The number of cells positive for TUNEL or activated caspase-3 was quantified
as a percentage of total lesional cells in macrophage-rich regions.
Atherosclerotic Lesion Analysis
Formorphometric lesion analysis, sections were stained with Harris’ hematox-
ylin and eosin. The total lesion area and necrotic area were quantified as previ-
ously described (Seimon et al., 2009). For plaque necrosis, boundary lines
were drawn around regions that were free of H&E staining, and area measure-
ments were obtained using image analysis software. A 3000 mm2 threshold
was implemented in order to avoid counting regions that likely do not represent
substantial areas of necrosis. Using this method, a 97% agreement in the
percent necrotic area was calculated between our two independent
observers. The methods for DHE and p47phox staining appear in the Supple-
mental Experimental Procedures.552 Cell Metabolism 15, 545–553, April 4, 2012 ª2012 Elsevier Inc.Statistics
Values are given as means ± SEM (n = 4 unless otherwise noted in the figure
legends); absent error bars in the bar graphs signify S.E.M. values smaller
than the graphic symbols. Comparison of mean values between groups was
evaluated using a two-tailed Student’s t test, Mann-Whitney U test, or
ANOVA. P values less than 0.05 were considered significant. Refer to the
legend of Figure S3C for additional statistical methods specific for the analysis
of the data in that panel.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at doi:10.1016/j.cmet.2012.01.022.
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